<DOC>
	<DOCNO>NCT01771081</DOCNO>
	<brief_summary>POLARIS : A non-interventional study patient diabetic macular edema ( DME ) central involvement ass effectiveness exist anti-vascular endothelial growth factor ( anti-VEGF ) treatment regimen .</brief_summary>
	<brief_title>Evaluation Changes Visual Acuity Patients With Diabetic Macular Edema ( DME ) Starting Treatment With Approved Anti-VEGF Therapy</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Patients diagnose type 1 2 diabetes mellitus Patients diagnose DME central involvement ( defined area center subfield optical coherence tomography [ OCT ] ) Patients decision make treat approve antiVEGF therapy prior inclusion study Patients receive first approve intravitreal anti VEGF treatment October 01 , 2012 Patients give informed consent write study participation Treatment antiVEGF therapy prior start observation period ( October 01 , 2012 ) enrolment study Participation investigational program intervention clinical routine practice</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Longitudinal Studies ,</keyword>
	<keyword>Observation</keyword>
	<keyword>Epidemiology</keyword>
</DOC>